QUIBIM PRECISION®

Quantitative Radiology solution for innovative doctors, researchers and clinical trial companies

REQUEST YOUR ACCOUNT

FROM IMAGES TO DATA, POWERED BY ARTIFICIAL INTELLIGENCE AND RADIOMICS

NEURO | MSK | LUNG | LIVER | ONCOLOGY

REQUEST AN ACCOUNT

YOUR PRECISION IMAGING COMPANY

First company to provide the precision and accuracy of measurements

REQUEST YOUR ACCOUNT

REAL TIME CLINICAL TRIALS

QUIBIM Precision platform is FDA 21 CFR Part 11 compliant and allows for the centralized storage, management and advanced analysis of medical images

REQUEST YOUR ACCOUNT

THE QUANTITATIVE IMAGING SOLUTION FOR HOSPITALS AND RADIOLOGY DEPARTMENTS

Add value to your clinical practice integrating QUIBIM Precision in your workflow

REQUEST YOUR ACCOUNT
ONE TECHNOLOGY, TWO SOLUTIONS

QUIBIM Care | QUIBIM Trials

QUIBIM Care:
Innovative Medical Doctors

We assist in the full process of imaging biomarkers integration, from the optimization of the images acquisition in the equipments to the imaging biomarkers report integration into the PACS. The platform can be either installed locally or used as a service in the Cloud, thanks to our interoperability.

Read more

QUIBIM Trials:
Researchers, CRO’s and Pharmaceutical companies

Our platform allows to centrally manage, store and quantitatively analyze the images, providing the ‘real time clinical trial’ concept. The platform allows to select the best patients and to early evaluate treatment response.

Read more

When extracting imaging biomarkers, the uncertainty of the measurements should be controlled

QUIBIM adds transparency to the validation of Imaging Biomarkers
by providing information on precision, accuracy and clinical utility

INFO ON PRECISION & ACCURACY

Liver fat & iron imaging biomarkers provided by QUIBIM allow to diagnose and follow-up patients with diffuse liver disorders

Dr. Manuela França, Chief of Radiology Department at Hospital Geral de Santo António, Porto, PT

The use of biomarkers is crucial for diagnosis: the medicine of the future can anticipate to the symptoms of the disease through the use of new biomarkers

Dr. Manuel Pérez Alonso, Profesor of Genetics at the University of Valencia, Spain

Image Biomarkers provided by QUIBIM are important to determine the risk of age associated frailty and dependency

Dr. Jose Viña, Professor of Human Physiology at the University of Valencia, Spain

A paradigm shift from qualitative to quantitative analysis of diagnostic imaging data like the one proposed by QUIBIM is absolutely necessary to give value to our profession in the near future

Dr. Andrea Laghi, Director of “Advanced Diagnostic Imaging” Unit at I.C.O.T. University Hospital, Latina, Italy

Imaging Biomarkers provided by QUIBIM should be also defined “radiomics” because they will be an essential component of the so called “systems medicine” and “omics”.

Dr. Emanuele Neri, Professor of Translational Research and New Medical Technologies Department, Pisa University, Italy

QUIBIM Imaging Biomarkers are the disruptive change needed in Precision Medicine, as they resolve in space and in time the patients’ needs

Dr. Luis MartÍ-Bonmatí, Head of the Clinical Area of Medical Imaging at La Fe Polytechnics & University Hospital, Valencia, Spain
TRY QUIBIM PRECISION

DISCOVER THE ADVANTAGES OF INTEGRATING IMAGING BIOMARKERS IN YOUR CLINICAL PRACTICE, RESEARCH OR CLINICAL TRIALS

REQUEST YOUR ACCOUNT